ClinicalTrialsFinder

Lower Risk MDS Per IPSS-R Clinical Trials in Tianjin, Tianjin Municipality

1 recruitingTianjin, Tianjin Municipality, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

The Tapering Dose of Luspatercept in Patients With Lower-risk Myelodysplastic Syndromes

Lower Risk MDS Per IPSS-R
Institute of Hematology & Blood Diseases Hospital, China36 enrolled1 locationNCT05925504